Skip to Content

Month: October 2021

Austria’s president swears in new chancellor

BERLIN (AP) — Austria has a new chancellor, two days after Chancellor Sebastian Kurz resigned amid corruption allegations. Austrian President Alexander Van der Bellen on Monday swore in Alexander Schallenberg, currently the foreign minister, as chancellor. Career diplomat Michael Linhart will become the country’s new foreign minister, Austrian news agency APA reported. Kurz announced Saturday

Continue Reading

Russia’s new COVID-19 infections, deaths near all-time highs

By VLADIMIR ISACHENKOV Associated Press MOSCOW (AP) — Russia’s daily coronavirus infections and deaths are hovering near all-time highs amid a lagging vaccination rate and the Kremlin’s reluctance to toughen restrictions. Russia’s state coronavirus task force reported 29,409 new confirmed cases Monday. That’s the highest number this year and just slightly lower than the pandemic

Continue Reading

Russia’s new COVID-19 infections, deaths near all-time highs

By VLADIMIR ISACHENKOV Associated Press MOSCOW (AP) — Russia’s daily coronavirus infections and deaths are hovering near all-time highs amid a lagging vaccination rate and the Kremlin’s reluctance to toughen restrictions. Russia’s state coronavirus task force reported 29,409 new confirmed cases Monday. That’s the highest number this year and just slightly lower than the pandemic

Continue Reading
Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment

Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir

By Jamie Gumbrecht and Maggie Fox, CNN Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form.

Continue Reading

Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir

By Jamie Gumbrecht and Maggie Fox, CNN Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form.

Continue Reading
Skip to content